IRIS
LAULETTA, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.519
AS - Asia 2.255
EU - Europa 1.949
SA - Sud America 543
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 85
OC - Oceania 4
Totale 11.605
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.304
SG - Singapore 978
IT - Italia 668
CN - Cina 555
BR - Brasile 426
SE - Svezia 311
HK - Hong Kong 236
RU - Federazione Russa 203
DE - Germania 170
GB - Regno Unito 114
UA - Ucraina 114
FI - Finlandia 113
FR - Francia 108
VN - Vietnam 107
CA - Canada 93
IN - India 75
BD - Bangladesh 64
AR - Argentina 42
TR - Turchia 35
MX - Messico 34
ID - Indonesia 31
IQ - Iraq 23
JP - Giappone 23
ES - Italia 22
PL - Polonia 22
BE - Belgio 21
NL - Olanda 20
CO - Colombia 19
ZA - Sudafrica 18
PK - Pakistan 17
VE - Venezuela 16
CI - Costa d'Avorio 15
IE - Irlanda 15
SA - Arabia Saudita 15
IL - Israele 13
MA - Marocco 13
CR - Costa Rica 12
HN - Honduras 12
LT - Lituania 12
TT - Trinidad e Tobago 12
UZ - Uzbekistan 12
AT - Austria 11
PH - Filippine 11
MY - Malesia 10
EC - Ecuador 9
GT - Guatemala 9
NI - Nicaragua 9
CL - Cile 8
JO - Giordania 8
BO - Bolivia 7
CZ - Repubblica Ceca 7
NP - Nepal 7
PR - Porto Rico 7
PY - Paraguay 7
SV - El Salvador 7
TN - Tunisia 7
CW - ???statistics.table.value.countryCode.CW??? 6
EG - Egitto 6
KE - Kenya 6
AZ - Azerbaigian 5
JM - Giamaica 5
PA - Panama 5
AU - Australia 4
BH - Bahrain 4
ET - Etiopia 4
GP - Guadalupe 4
LB - Libano 4
OM - Oman 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
KR - Corea 3
MU - Mauritius 3
SC - Seychelles 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
IR - Iran 2
LY - Libia 2
PE - Perù 2
SR - Suriname 2
CH - Svizzera 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
PT - Portogallo 1
Totale 11.353
Salva come PNG Salva come JPEG
Città #
Ashburn 738
Fairfield 623
Singapore 536
San Jose 506
Chandler 414
Woodbridge 392
Milan 258
Seattle 255
Cambridge 252
Jacksonville 248
Houston 242
Nyköping 238
Hong Kong 235
Beijing 199
Wilmington 189
Ann Arbor 172
Council Bluffs 111
New York 106
Rome 100
Santa Clara 89
Los Angeles 82
Lauterbourg 80
Roxbury 76
Lawrence 73
Nanjing 70
Dallas 69
Boardman 56
Bari 53
Des Moines 53
Brooklyn 47
Princeton 47
Helsinki 46
São Paulo 42
Munich 38
Inglewood 37
Columbus 33
San Diego 30
Buffalo 27
Toronto 26
Ho Chi Minh City 25
Figino 24
Nanchang 24
Hebei 23
London 23
Tokyo 23
Brussels 21
Montreal 21
Dong Ket 20
Hanoi 20
Shenyang 20
Chicago 19
San Francisco 19
Jakarta 18
Phoenix 18
Denver 16
Falkenstein 16
Warsaw 16
Abidjan 15
Jiaxing 15
Dublin 14
Orem 14
Pune 14
Tianjin 14
Belo Horizonte 13
Frankfurt am Main 13
Ankara 12
Boston 12
Moscow 12
Tashkent 12
Turin 12
Atlanta 11
Changsha 11
Guangzhou 10
Jinan 10
Stockholm 10
The Dalles 10
Charlotte 9
Chennai 9
Grafing 9
Guatemala City 9
North Bergen 9
Nuremberg 9
Palermo 9
Paris 9
Amman 8
Baghdad 8
Brasília 8
Guarulhos 8
Ostuni 8
Poplar 8
Shanghai 8
Washington 8
Bologna 7
Brescia 7
Casablanca 7
Catania 7
Haiphong 7
Johannesburg 7
Kuala Lumpur 7
Queens 7
Totale 7.680
Salva come PNG Salva come JPEG
Nome #
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 237
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 233
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 218
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 213
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 210
CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia 208
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 204
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 197
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 184
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 171
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 170
B CELLS AND HCV: AN INFECTION MODEL OF AUTOIMMUNITY 168
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 167
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 163
IN SITU SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS-RELATED ANTIGENS IN HEPATOCELLULAR CARCINOMA 162
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 161
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 160
B-cell depletion in the treatment of mixed cryoglobulinemia. 159
Hepatitis C virus infection and mixed cryoglobulinemia 158
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 155
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 151
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 151
Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study 149
A Challenging Case of Visceral Leishmaniasis 148
H. pylori infection and gastric cancer: state of the art (review). 145
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial. 144
Barrett's esophagus and esophageal cancer: An overview. 143
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association 142
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins 140
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay 139
Features of peripheral CD8+CD57+ lymphocytes in patients with autoimmune hemolytic anemia 138
C4d: a valuable marker of activation of the classical complement pathway in mixed cryoglobulinemia 135
Role of B-cell attracting chemokine-1 in HCV-related cryoglobulinemic vasculitis 134
INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS 134
MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20 134
Assessment of total Hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia. 134
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. 131
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 131
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 127
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 126
Antikörper gegen hepatitis-C-viren in humanen intravenösen immunoglobulinen. 123
null 122
HEPATITIS C VIRUS RNA AND CORE PROTEIN IN KIDNEY GLOMERULAR AND TUBULAR STRUCTURES ISOLATED WITH LASER CAPTURE MICRODISSECTION 122
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 120
Crioglobulinemia mista e infezione da HCV 119
REPLY TO THE LETTER TO THE EDITOR "ANDROGEN DEPRIVATION THERAPY AND RISK OF RHEUMATOID ARTHRITIS IN PATIENTS WITH LOCALIZED PROSTATE CANCER" by YANG et al. 119
HCV-ASSOCIATED B CELL CLONALITIES IN THE LIVER DO NOT CARRY THE T(14; 18) CHROMOSOMAL TRANSLOCATION 118
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 117
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite (HCV) con e senza crioglobulinemia mista 116
MIXED CRYOGLOBULINEMIA: A MODEL OF VIRUS-RELATED DISEASE IN INTERNAL MEDICINE 115
Association Between Mixed Cryoglobulinemia, Translocation (14;18), and Persistence of Occult HCV Lymphoid Infection After Treatment 114
Basi molecolari dell’associazione tra virus epatite e carcinoma epatocellulare 113
Cryoglobulinemic Vasculitis 112
Alcolizzazione percutanea del piccolo HCC. Casistica personale 112
IMMUNOCHEMICAL AND BIOMOLECULAR STUDIES OF CIRCULATING IMMUNE COMPLEXES ISOLATED FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS C VIRUS INFECTION 110
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite con e senza crioglobulinemia mista 104
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 104
PEGYLATED INTERFERON-A, RIBAVIRIN AND RITUXIMAB COMBINED THERAPY OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA: A LONG-TERM STUDY 103
Vasculiti primarie sistemiche 102
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 100
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 100
Cellule ematopoietiche staminali CD34+ e infezione cronica da virus C dell'epatite 98
In reply. Transarterial chemoembolization plus sorafenib... 97
HCV, Mixed Cryoglobulinemia and Malignant Lymphoproliferation 97
null 96
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 94
T cell receptor variable beta gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia 94
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature 93
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 92
Double filtration plasmapheresis in the treatment of leg ulcers in the course of type IHCV-positive cryoglobulinemia 92
Potential neutralizing properties of anti-E2 antibodies in HCV-infected patients with lymphoproliferative disorders. 91
VIROLOGICAL ANALYSIS AND PHENOTIPIC CHARACTERIZATION OF PERIPHERAL BLOOD LYMPHOCYTES OF HEPATITIS C VIRUS-INFECTED PATIENTS WITH AND WITHOUT MIXED CRYOGLOBULINEMIA 90
Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment 89
Le tecniche di biologia molecolare nello studio dei tessuti fissati e paraffinati 88
P87 MEDIASTINAL SYNDROME REVEALED HEART LOCALIZATION OF A PRIMARY MEDIASTINAL B-CELL LYMPHOMA 87
Termoablazione a radiofrequenza vs alcolizzazione percutanea nel trattamento del piccolo epatocarcinoma. Studio prospettico, randomizzato 87
Serum IgM in type II mixed cryoglobulinemia recognize HCV E2 peptides 86
Trattamento con interferone pegilato-α2b in monoterapia o in associazione con ribavirina e amantadina in pazienti affetti da epatite cronica attiva HCV-correlata non responsivi a interferone non-pegilato 85
Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study 82
ROLE OF THE RECEPTOR FOR THE GLOBULAR DOMAIN OF C1Q PROTEIN IN THE PATHOGENESIS OF CRYOGLOBULIN-RELATED VASCULAR DAMAGE 82
La vasculite crioglobulinemica: aspetti clinico-patogenetici 80
null 78
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 74
Natural interferon-Α versus its combination with 6-methyl prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term randomized, controlled study 74
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinemia 74
Cryoglobulinemia: the "cold" problem in cardiac surgery, a single-center experience and a literature review 73
Trattamento antivirale in pazienti affetti da epatite cronica attiva HCV correlata e transaminasi normali 72
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements 65
Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation 65
Immunodetection of hepatitis C virus (HCV)-related antigens in tissues: problems and perspectives 64
null 61
Role of the receptor for the globular domain of C1q protein in the pathogenesis of HCV-related cryoglobulin vascular damage 56
Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis. 54
Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia 53
null 47
Terapia della sindrome crioglobulinemica 40
⁠From liver to cardiovascular system: the MASLD–ASCVD continuum 11
HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers 5
Totale 11.605
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.381
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022492 0 0 0 0 26 55 28 29 41 52 114 147
2022/20231.097 146 117 78 98 105 168 14 153 169 4 25 20
2023/2024380 33 77 16 25 34 93 20 19 4 8 4 47
2024/20251.595 35 25 131 44 31 147 200 140 58 79 235 470
2025/20263.555 475 158 156 331 401 196 436 80 435 277 146 464
2026/20271.097 105 217 274 476 25 0 0 0 0 0 0 0
Totale 11.605